Pleural Mesothelioma (MSK, Clin Cancer Res 2024)

Summary

Pleural Mesothelioma (MSK, Clin Cancer Res 2024) is a study catalogued by cBioPortal DataHub under the cancer-type code plmeso. EvidenceHelix groups it with lung and pleura studies.

Study description

Targeted sequencing of 14 genomic near-haploidization (GNH) pleural mesothelioma samples and their matched normals via MSK-IMPACT.

Text as published in the source's study metadata.

Citation & PubMed

Yang, Soo-Ryum et al. Clin Cancer Res 2024

Linked PubMed records: PMID 38630790

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

plmeso_msk_2024

Short name

not given

Source cancer-type code

plmeso

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Yang, Soo-Ryum et al. Clin Cancer Res 2024

• PubMed record 38630790 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Mesothelioma (TCGA, Firehose Legacy)

  TCGA Mesothelioma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/MESO/20160128/). Previously known as TCGA Provisional.

  Lung and pleuraTCGA Firehose LegacySource code plmeso

• Mesothelioma (TCGA, PanCancer Atlas)

  Mesothelioma TCGA PanCancer data. The original data is here (https://gdc.cancer.gov/about-data/publications/pancanatlas). The publications are here (https://www.cell.com/pb-assets/consortium/pancanceratlas/pancani3/in…

  Lung and pleuraTCGA PanCancer AtlasSource code plmesoPubMed 11

• Pleural Mesothelioma (NYU, Cancer Res 2015)

  Whole-exome sequencing of 22 malignant pleural mesotheliomas (PLMESO) tumor/normal pairs.

  Lung and pleuraOther published and consortium studiesSource code plmesoPubMed 1

• Atypical Small Cell Lung Cancer (MSK, Cancer Discov 2024)

  Targeted sequencing of 31 atypical small cell lung cancers lacking RB1 and TP53 co-inactivation and their matched normals via MSK-IMPACT, including structural variant analysis via whole-genome sequencing. This data is…

  Lung and pleuraMSK studiesSource code lungPubMed 1

• Lung Adenocarcinoma (MSK Mind,Nature Cancer 2022)

  Multimodality tools to predict response to PD-(L)1 blockade in patients with lung adenocarcinoma.

  Lung and pleuraMSK studiesSource code lungPubMed 1

• Lung Adenocarcinoma (MSK, 2021)

  Targeted sequencing of 186 matched normal samples from 186 lung adenocarcinoma patient via MSK-IMPACT.

  Lung and pleuraMSK studiesSource code luad

• Lung Adenocarcinoma (MSK, J Thorac Oncol 2020)

  Targeted sequencing of 604 lung adenocarcinoma tumor/normal pairs via MSK-IMPACT.

  Lung and pleuraMSK studiesSource code luadPubMed 1

• Lung Adenocarcinoma (MSK, NPJ Precision Oncology 2021)

  Targeted sequencing of 426 matched normal samples from 426 lung adenocarcinoma patients.

  Lung and pleuraMSK studiesSource code luadPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.